Silence Therapeutics SLN Balance Sheet (2018-2026)

NASDAQ SLN
$14.62 -0.17 (-1.15%)
As of: Sep 4, 2026 · 2:23 PM EDT
Reported Financials

Silence Therapeutics Quarterly Balance Sheet

Periods 16 quarters
Latest Jun 2026

Silence Therapeutics reported total assets of $106.41M and total liabilities of $67.94M for the quarter ended Jun 2026, down 35.6% year over year. This balance sheet covers 16 quarters of results from Dec 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv. 27.66M17.38M36.25M99.13M64.30M67.06M121.33M136.50M114.20M102.20M11.28M70.10M72.10M
Short-term InvestmentsInvestments (Current) 19.81M0.53M36.97M64.74M71.65M72.42M20.16M73.84M64.42M
Cash & Current Investments 27.66M17.38M56.05M99.13M64.83M67.06M186.07M208.15M186.62M122.36M85.11M134.52M72.10M
Receivables - NetNet Receivables 0.01M38.70M0.45M1.07M0.28M0.97M0.04M0.09M0.03M
Receivables 0.01M38.70M0.45M1.07M0.28M0.97M0.04M0.09M0.03M
Prepaid Assets 11.63M14.66M16.42M14.36M9.26M11.54M10.56M12.94M
Current Assets 37.96M48.17M100.88M116.38M113.41M100.56M187.37M169.79M148.55M133.63M118.66M102.85M94.28M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net) 12.08M11.07M12.64M13.29M12.68M15.89M1.82M1.69M1.77M1.66M1.58M1.40M1.32M
Goodwill 10.46M9.89M10.73M10.23M9.39M9.73M9.76M9.39M9.39M10.62M10.62M10.61M10.62M10.36M10.32M
Intangibles 0.08M0.04M0.02M0.18M0.50M0.53M0.31M0.31M0.32M0.30M0.29M0.25M0.24M
Goodwill & Intangibles 10.54M9.93M10.75M10.41M9.90M10.26M9.76M9.39M9.70M10.93M10.94M10.91M10.91M10.61M10.56M
Long-Term Deferred Tax 0.02M0.03M0.03M
Other Non-Current Assets 3.20M3.59M3.61M3.91M0.40M0.13M0.13M0.13M
Non-Current Assets -37.96M-48.17M-100.88M-116.38M-113.41M-100.56M15.27M15.51M16.68M13.16M12.78M12.27M12.13M
Assets 202.63M185.30M165.23M146.79M131.44M115.12M106.41M
Liabilities
Current Liabilities
Accounts Payables 4.93M8.86M10.82M14.54M14.82M15.43M16.40M18.81M14.31M16.99M13.36M10.37M12.61M
Payables 4.93M8.86M10.82M14.54M14.82M15.43M16.40M18.81M14.31M16.99M13.36M10.37M12.61M
Current Leases 0.23M0.12M0.06M0.09M0.09M0.09M0.10M
Current Deferred Revenue 6.57M0.31M0.39M0.46M0.30M0.17M
Total Current Liabilities 4.93M12.41M33.77M20.45M25.74M22.05M16.82M19.26M14.77M17.38M13.61M10.46M12.71M
Non-Current Liabilities
Non-Current Deffered Revenue 75.00M51.79M53.29M56.31M55.25M55.45M55.22M55.22M
Non-Current Deferred Tax LiabilityNon-Current Deferred Tax 0.02M0.03M0.03M
Operating Leases 0.12M0.10M0.07M0.04M0.01M
Total Non-Current Liabilities 19.95M67.79M97.73M74.46M73.23M
Total Liabilities -45.11M-26.88M-11.96M-11.49M-25.89M-21.16M-156.76M-142.53M-126.70M68.61M72.56M71.08M72.73M69.14M65.72M67.94M
Shareholder's Equity
Common Equity 45.11M26.88M11.96M11.49M25.89M21.16M156.76M142.53M126.70M134.02M112.74M94.16M74.06M62.30M49.40M38.47M
Liabilities and Shareholders Equity 202.63M185.30M165.23M146.79M131.44M115.12M106.41M
Retained Earnings -172.14M-195.43M-243.25M-300.56M-308.79M-378.07M-474.04M-502.54M-529.84M-550.80M-562.57M-577.53M-589.63M